SCHEMBL25523958

SCHEMBL25523958

CC(C)c1ncc(-c2ccnc3c(Cl)cccc23)cc1O

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ NR1H2 P55055 2/20 0.46
▸ NR1H3 Q13133 2/20 0.46
▸ NR4A2 P43354 1/20 0.40
▸ PDE4D Q08499 1/20 0.39
▸ PTGDR2 Q9Y5Y4 1/20 0.38
▸ PIK3CD O00329 1/20 0.37
▸ KDM4E B2RXH2 6/20 0.37
▸ SMN1; SMN2 Q16637 4/20 0.37
▸ HSP90AA1 P07900 4/20 0.37
▸ ALDH1A1 P00352 3/20 0.37
▸ LMNA P02545 3/20 0.37
▸ MAPT P10636 3/20 0.37
▸ MMP14 P50281 3/20 0.37
▸ HTT P42858 3/20 0.37
▸ MEN1 O00255 2/20 0.37
▸ TP53 P04637 2/20 0.37
▸ CYP3A4 P08684 2/20 0.37
▸ ALOX15 P16050 2/20 0.37
▸ ALOX12 P18054 2/20 0.37
▸ SLC6A2 P23975 2/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25521799 0.85 TOP2A (0.40) NR1H2NR1H3PTGDR2PIK3CDKDM4E
SCHEMBL25521547 0.84 NR1H2 (0.46) NR1H2NR1H3NR4A2PDE4DPTGDR2
SCHEMBL25521925 0.81 NR1H2 (0.35) NR1H2NR1H3PTGDR2KDM4ESMN1; SMN2
SCHEMBL25521916 0.76 ERN1 (0.46) MMP9AAK1
SCHEMBL25522060 0.76 HSP90AA1 (0.34) HSP90AA1
SCHEMBL4016535 0.73 PIK3CD (0.61) NR1H2NR1H3NR4A2PDE4DPTGDR2
SCHEMBL27809134 0.73 NR4A2 (0.51) NR1H2NR1H3NR4A2PDE4DPTGDR2
SCHEMBL27809136 0.73 NR4A2 (0.51) NR1H2NR1H3NR4A2PDE4DPTGDR2
SCHEMBL25521800 0.72 AAK1 (0.47) AAK1
SCHEMBL25523903 0.72 KDM4E (0.40) PIK3CDKDM4EALDH1A1LMNAMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023086428-A2 NOVEL MODULATORS OF THE ARYL HYDROCARBON RECEPTOR AND METHODS OF USE THEREOF ALLIANTHERA (SUZHOU) BIOPHARMACEUTICAL CO., LTD. (CN) 2023-05-19 — — WO disclosed
Send feedback